Skip to main content
PMC home page
Oncotarget logoLink to Oncotarget
. 2018 Aug 17;9(64):32403. doi: 10.18632/oncotarget.26020

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance

Man Kit Siu 1,2,#, Wassim Abou-Kheir 3,#, Juan Juan Yin 4,#, Yung-Sheng Chang 1, Ben Barrett 4, Florent Suau 4, Orla Casey 4, Wei-Yu Chen 5, Lei Fang 4, Paul Hynes 4, Yao-Yu Hsieh 1,6,9, Yen-Nien Liu 1,7, Jiaoti Huang 8, Kathleen Kelly 4
PMCID: PMC6122359  PMID: 30190798

This article has been corrected: The author affiliation is given below:

Yao-Yu Hsieh1,6,9

9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Original article: Oncotarget. 2014; 5:3770-3784. https://doi.org/10.18632/oncotarget.1994

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES